MicroPort Endovascular MedTech Ltd Asset Resilience Ratio

Latest as of June 2026: 18.30%

MicroPort Endovascular MedTech Ltd asset resilience ratio. MicroPort Endovascular MedTech Ltd (688016) has an Asset Resilience Ratio of 18.30% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688016 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥906.83 Million
≈ $132.70 Million USD Cash + Short-term Investments

Total Assets

CN¥4.96 Billion
≈ $725.32 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio of MicroPort Endovascular MedTech Ltd (2025–2025)

Asset resilience ratio of MicroPort Endovascular MedTech Ltd from 2025 to 2025. This chart shows how MicroPort Endovascular MedTech Ltd's Asset Resilience Ratio has changed over time. Read 688016 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down MicroPort Endovascular MedTech Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see MicroPort Endovascular MedTech Ltd (688016) total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥906.83 Million 18.3%
Total Liquid Assets CN¥906.83 Million 18.30%

Asset Resilience Insights

  • Good Liquidity Position: MicroPort Endovascular MedTech Ltd maintains a healthy 18.30% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

MicroPort Endovascular MedTech Ltd Industry Peers by Asset Resilience Ratio

Compare MicroPort Endovascular MedTech Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Vitrolife AB
ST:VITR
Medical Devices 7.27%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
Shanghai Sanyou Medical Co Ltd
SHG:688085
Medical Devices 7.69%
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
Medical Devices 2.82%
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
Medical Devices 10.74%
TAIDOC TECHNOLOGY CORP
TW:4736
Medical Devices 23.03%
Dirui Industrial Co Ltd
SHE:300396
Medical Devices 3.90%

MicroPort Endovascular MedTech Ltd Asset Resilience Ratio by Year (2025–2025)

MicroPort Endovascular MedTech Ltd asset resilience ratio by year from 2025 to 2025. The table below shows the annual Asset Resilience Ratio data for MicroPort Endovascular MedTech Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 2.16% CN¥100.37 Million
≈ $14.69 Million
CN¥4.64 Billion
≈ $679.15 Million
--
pp = percentage points

About MicroPort Endovascular MedTech Ltd

SHG:688016 China Medical Devices
Market Cap
$1.58 Billion
CN¥10.82 Billion CNY
Market Cap Rank
#6773 Global
#1361 in China
Share Price
CN¥87.78
Change (1 day)
-1.25%
52-Week Range
CN¥82.40 - CN¥111.80
All Time High
CN¥443.37
About

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, sale, and services of aortic, peripheral vascular, and tumor intervention devices in China and internationally. The company offers Fontus, a branched stent graft system in surgical operation; CRONUS, a stent graft system in surgical operation; Hector, a multi-branch thoracic stent graft syste… Read more